ArticleComputational and structural biotechnology journal2022

P2X3-selective mechanism of Gefapixant, a drug candidate for the treatment of refractory chronic cough.

Wen-Wen Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.